StockData
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc. (AIDX) stock

AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3068% below fair value
$0.19−0.00 (-1.01%)

Close on Nov 18, 2026Market cap $2.37MP/E –Yield –

20/20 Biolabs net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$3.74M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.74M–
FY2024Dec 31, 2024-$5.55M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.51M–
Q1 FY2026Mar 31, 2026-$2.17M–
Q2 FY2025Jun 30, 2025-$840.93K–
Q1 FY2025Mar 31, 2025-$764.58K–

More 20/20 Biolabs figures

See a number that looks wrong?